Revenue Increases 22.8% as Demand Remains Strong and Supply Chain Conditions Ease; Backlog and Long-Term Agreements Reach Record
Financial highlights:
- Revenues were
$52.9 million , a 22.8% increase compared to$43.1 million in the second quarter of 2025. For the first half of 2026, revenues increased by 10.4% to$94.1 million compared to$85.2 million in the first half of 2025. - Gross profit increased by 23.0% to
$13.3 million , representing 25.2% of revenues, compared to$10.8 million (25.1% of revenues) in the second quarter of 2025. For the first half of 2026, gross profit increased by 12.4% to$23.4 million compared to$20.8 million in the first half of 2025 (24.8% of revenues in the first half of 2026 compared to 24.4% of revenues in the first half of 2025). - Operating Income increased by 26.8% to
$5.6 million (10.6% of revenues) compared to$4.4 million (10.3% of revenues) for Q2 2025. For the first half of 2026, operating income was$8.6 million (9.1% of revenues) compared to$8.6 million (10.1% of revenues) in the first half of 2025 - Net Income of
$8.1 million (Diluted EPS of$0.61 ) compared to$3.4 million for Q2 2025 (Diluted EPS of$0.3 ). The second quarter of 2026 included a$4.3 million (Diluted EPS of$0.26 ) net of tax, non-operating gain from the sale of a minority interest in an unconsolidated entity. Excluding the non-recurring benefit, net income would have been$4.66 million , an increase of 35.2% compared to the previous period (and Adjusted Diluted EPS of$0.35 ). For the first six months of the year, net profit was$11.5 (Diluted EPS of $0.87) million. Excluding the one-time net impact of the minority interest sale, net profit for the first six months was$8.06 million , an increase of 11.0% compared to$7.3 million in the previous period. - Adjusted EBITDA was
$7.4 million (14.0% of revenues), a 22.7% increase from$6.1 million (14.0% of revenues) for Q2 2025. Adjusted EBITDA for the first half of 2026 increased by 4.1% to$12.3 million (13.1% of revenues) compared to$11.8 million (13.8% of revenues) in the first half of 2025. - Cash flow used in operations for the second quarter was
$(0.6) million compared to$6.9 million provided by operations in Q2 2025. Cash flow from operations was$1.4 million in the first half of 2026 compared to$1.9 million in the first half of 2025. - Backlog and Long-Term Agreements: approximately
$615 million as ofJune 30, 2026 , up from approximately$580 million onMarch 31, 2026 , reflecting continued strong customer demand and providing multi-year revenue visibility.
"Continued strong demand and solid execution drove nearly 23% revenue growth and continued profitability improvements," said
"We have expanded our strategic relationship with Honeywell Aerospace" Zamir continued. "We became the sole authorized distributor(*) of spare parts for the 331-200 auxiliary power unit platform (APU), extended our MRO license through 2036, and acquired three
"We believe the combination of historically high customer demand, expanding platform coverage, and a record backlog, combined with improving supply chain conditions, positions TAT well for continued profitable growth," Concluded Zamir.
(*) As previously disclosed in the Company's Report on Form 6-K filed on
Investor Call Information
Webcast Registration: https://us06web.zoom.us/webinar/register/WN_MRtan_3wQoG9XfDYLkuNeA
Investor Relations Website: https://tat-technologies.com/investors/
Non-GAAP Financial Measures
To supplement its GAAP results, the Company presents Adjusted EBITDA to provide investors with additional insight into underlying operating performance. Adjusted EBITDA excludes the Company's share in results of affiliated companies, share-based compensation, income taxes, net financial (expenses) income, and depreciation and amortization. Adjusted EBITDA should not be considered as an alternative to net income and operating income for the period and may not be indicative of the historic operating results of the Company; nor is it meant to be predictive of potential future results. Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles and may not be comparable to other similarly titled measures for other companies. See reconciliation of Adjusted EBITDA below.
About
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of
Contact:
Director of IR
Tel: +1-980-451-1115
erany@tat-technologies.com
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | |||
2026 | 2025 | ||
ASSETS | |||
CURRENT ASSETS: | |||
Cash and cash equivalents | |||
Accounts receivable, net of allowance for credit losses of |
38,813 |
33,420 | |
Inventory | 85,189 | 75,549 | |
Prepaid expenses and other current assets | 7,041 | 6,071 | |
Total current assets | 185,672 | 166,299 | |
NON-CURRENT ASSETS: | |||
Property, plant and equipment, net | 47,001 | 46,922 | |
Operating lease right of use assets | 5,285 | 5,807 | |
Intangible assets, net | 1,884 | 1,452 | |
Investment in affiliates | 5,726 | 4,905 | |
Funds in respect of employee rights upon retirement | 446 | 398 | |
Deferred tax assets | 573 | 639 | |
Restricted deposit | - | 307 | |
Total non-current assets | 60,915 | 60,430 | |
Total assets | |||
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | |||
2026 | 2025 | ||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||
CURRENT LIABILITIES: | |||
Current maturities of long-term debts | |||
Accounts payable | 18,531 | 12,986 | |
Accrued expenses and other current liabilities | 18,309 | 17,296 | |
Current maturities of operating lease liabilities | 1,459 | 1,474 | |
Total current liabilities | 38,463 | 33,983 | |
NON-CURRENT LIABILITIES: | |||
Long-term debts, net | 11,018 | 9,485 | |
Operating lease liabilities | 4,032 | 4,448 | |
Liability in respect of employee rights upon retirement | 853 | 770 | |
Deferred tax liabilities | 3,286 | 1,652 | |
Total non-current liabilities | 19,189 | 16,355 | |
COMMITMENTS AND CONTINGENCIES (NOTE 7) | - | - | |
Total liabilities | 57,652 | 50,338 | |
SHAREHOLDERS' EQUITY: | |||
Ordinary shares of Authorized: 19,000,000 shares at Issued:13,272,610 shares at Outstanding: 12,998,137 shares at | - | - | |
Additional paid-in capital | 137,567 | 136,578 | |
(2,088) | (2,088) | ||
Accumulated other comprehensive income | 727 | 643 | |
Retained earnings | 52,729 | 41,258 | |
Total shareholders' equity | 188,935 | 176,391 | |
Total liabilities and shareholders' equity | |||
TAT TECHNOLOGIES LTD. | |||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||
Three Months Ended | Six Months Ended | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Revenues: | |||||||
Products | |||||||
Services | 37,609 | 30,641 | 64,850 | 60,059 | |||
52,938 | 43,104 | 94,085 | 85,246 | ||||
Costs: | |||||||
Products | 10,775 | 9,112 | 20,874 | 17,443 | |||
Services | 28,843 | 23,167 | 49,860 | 47,024 | |||
39,618 | 32,279 | 70,734 | 64,467 | ||||
Gross profit | 13,320 | 10,825 | 23,351 | 20,779 | |||
Operating expenses: | |||||||
Research and development, net | 535 | 240 | 1,106 | 564 | |||
Selling and marketing | 2,530 | 2,185 | 4,712 | 4,113 | |||
General and administrative | 4,632 | 3,965 | 8,925 | 7,497 | |||
7,697 | 6,390 | 14,743 | 12,174 | ||||
Operating income | 5,623 | 4,435 | 8,608 | 8,605 | |||
Gain on sale of equity investment | 4,324 | - | 4,324 | - | |||
Interest expenses | (182) | (324) | (330) | (659) | |||
Other financial expenses, net | (368) | (776) | (181) | (499) | |||
Income before taxes on income | 9,397 | 3,335 | 12,421 | 7,447 | |||
Provision for income taxes | 1,911 | 211 | 2,056 | 803 | |||
Income before share of equity investment | 7,486 | 3,124 | 10,365 | 6,644 | |||
Share in profits of equity investment | 585 | 318 | 1,106 | 611 | |||
Net income | |||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||
Three Months Ended | Six Months Ended | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Earnings per share | |||||||
Basic | |||||||
Diluted | |||||||
Weighted average number of shares | |||||||
Basic | 12,987,471 | 11,447,986 | 12,985,316 | 11,196,992 | |||
Diluted | 13,131,610 | 11,666,309 | 13,164,168 | 11,409,488 | |||
TAT TECHNOLOGIES LTD. | |||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | |||||||
Three Months Ended June 30, | Six Months Ended | ||||||
2026 | 2025 | 2026 | 2025 | ||||
Net income | |||||||
Other comprehensive income (loss), net: | |||||||
Change in foreign currency translation adjustments | (100) | 148 | 91 | 676 | |||
Net unrealized losses from derivatives | (7) | - | (7) | - | |||
Total comprehensive income | |||||||
TAT TECHNOLOGIES LTD. | |||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY | |||||||||||
Share capital | Accumulated | ||||||||||
Number of | Amount | Additional | other | Retained earnings | Total equity | ||||||
BALANCE AT | 11,214,831 | $- | |||||||||
CHANGES DURING THE THREE MONTHS ENDED | |||||||||||
Comprehensive income | - | - | - | 148 | - | 3,442 | 3,590 | ||||
Exercise of stock option | 79,633 | - | - | - | - | - | - | ||||
Issuance of common shares on public offering, net of issuance costs of | 1,625,000 | - | 39,415 | - | - | - | 39,415 | ||||
Exercise of the underwriters' option on public offering, net of issuance | 242,298 | - | 5,953 | - | - | - | 5,953 | ||||
Share based compensation | - | - | 291 | - | - | - | 291 | ||||
BALANCE AT | 13,161,762 | $ - | |||||||||
BALANCE AT | 13,257,610 | $- | |||||||||
CHANGES DURING THE THREE MONTHS ENDED | |||||||||||
Comprehensive income | - | - | - | (107) | - | 8,071 | 7,964 | ||||
Exercise of stock option | 15,000 | - | 136 | - | - | - | 136 | ||||
Share based compensation | - | - | 360 | - | - | - | 360 | ||||
BALANCE AT | 13,272,610 | $- | |||||||||
TAT TECHNOLOGIES LTD. | |||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY | |||||||
Share capital | Accumulated | ||||||
Number of | Amount | Additional | other | Retained earnings | Total equity | ||
BALANCE AT | 11,214,831 | $- | |||||
CHANGES DURING THE SIX MONTHS ENDED | |||||||
Comprehensive income | - | - | - | 676 | - | 7,255 | 7,931 |
Exercise of option | 79,633 | - | - | - | - | - | - |
Issuance of common shares on public offering, net of issuance costs of | 1,625,000 | - | 39,415 | - | - | - | 39,415 |
Exercise of the underwriters' option on public offering, net of issuance | 242,298 | - | 5,953 | - | - | - | 5,953 |
Share based compensation | - | - | 513 | - | - | - | 513 |
BALANCE AT | 13,161,762 | $- | |||||
BALANCE AT | 13,257,610 | $- | |||||
CHANGES DURING THE SIX MONTHS ENDED | |||||||
Comprehensive income | - | - | - | 84 | - | 11,471 | 11,555 |
Exercise of option | 15,000 | - | 136 | - | - | - | 136 |
Share based compensation | - | - | 853 | - | - | - | 853 |
BALANCE AT | 13,272,610 | $- | |||||
TAT TECHNOLOGIES LTD. | |||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||
Three Months Ended | Six Months Ended | ||||||
2026 | 2025 | 2026 | 2025 | ||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
Net income | |||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization | 1,391 | 1,208 | 2,704 | 2,513 | |||
Non-cash financial expenses | 21 | 600 | 352 | 508 | |||
Gain on sale of equity investment (Note 4) | (4,324) | - | (4,324) | - | |||
Change in allowance for credit losses | (14) | 75 | 55 | 25 | |||
Share in profits of equity investment of affiliated companies | (585) | (318) | (1,106) | (611) | |||
Share based compensation | 360 | 291 | 853 | 513 | |||
Deferred income taxes, net | 1,615 | 63 | 1,700 | 582 | |||
Changes in operating assets and liabilities: | |||||||
Decrease (increase) in trade accounts receivable | (8,342) | 882 | (5,448) | (2,594) | |||
Increase in inventory | (3,453) | (3,434) | (9,883) | (7,295) | |||
Decrease (increase) in prepaid expenses and other current assets | 1,445 | 1,697 | (812) | 1,183 | |||
Increase in trade accounts payable | 2,403 | 2,972 | 4,874 | 3,406 | |||
Increase (decrease) in accrued expenses and other current liabilities | 850 | (529) | 952 | (3,571) | |||
Net cash provided by (used in) operating activities | (562) | 6,949 | 1,388 | 1,914 | |||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
Proceeds from sale of equity investment | 4,493 | - | 4,493 | - | |||
Purchase of property and equipment | (1,139) | (3,305) | (2,559) | (6,167) | |||
Net cash provided by (used in) investing activities | 3,354 | (3,305) | 1,934 | (6,167) | |||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
Repayment of short-term debts | - | (10,719) | - | (4,350) | |||
Repayments of long-term debts | (10,721) | (516) | (11,272) | (1,087) | |||
Proceeds from issuance of ordinary shares and exercise of the underwriters' option | - | 48,550 | - | 48,550 | |||
Issuance costs of ordinary shares and exercise of the underwriters' option | - | (2,820) | - | (2,820) | |||
Proceeds from long term debt, net | 10,877 | - | 10,877 | - | |||
Proceeds from exercise of options | 136 | - | 136 | - | |||
Net cash provided by (used in) financing activities | 292 | 34,495 | (259) | 40,293 | |||
Net increase in cash and cash equivalents and restricted cash | 3,084 | 38,139 | 3,063 | 36,040 | |||
Cash and cash equivalents and restricted cash at beginning of period | 51,545 | 5,335 | 51,566 | 7,434 | |||
Cash and cash equivalents and restricted cash at the end of period | |||||||
Supplementary information on investing and financing activities not involving cash flows: | |||||||
Additions of operating lease right-of-use assets and operating lease liabilities | |||||||
Reclassification between inventory and property, plant and equipment | - | - | - | 579 | |||
Unpaid issuance costs on long term debt and issuance of shares | 152 | 362 | 152 | 362 | |||
Unpaid addition to property and equipment and intangible assets | 1,140 | 951 | 1,140 | 951 | |||
Supplemental disclosure of cash flow information: | |||||||
Interest paid | 154 | 249 | 303 | 516 | |||
Taxes paid | 79 | 176 | 192 | 195 | |||
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (NON-GAAP) (UNAUDITED)
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (NON-GAAP) (UNAUDITED) | |||||||||
Three months ended | Six months ended | ||||||||
2026 | 2025 | 2026 | 2025 | ||||||
Net income | |||||||||
Adjustments: | |||||||||
Share in profits of equity investment of affiliated companies | (585) | (318) | (1,106) | (611) | |||||
Provision for income taxes | 1,911 | 211 | 2,056 | 803 | |||||
Interest expenses | 182 | 324 | 330 | 659 | |||||
Gain on sale of equity investment | (4,324) | - | (4,324) | - | |||||
Other financial expenses, net | 368 | 776 | 181 | 499 | |||||
Depreciation, amortization and others | 1,445 | 1,328 | 2,820 | 2,691 | |||||
Share based compensation | 360 | 291 | 853 | 513 | |||||
Adjusted EBITDA | |||||||||
ADJUSTED NET INCOME ATTRIBUTABLE TO TAT TECHNOLOGIES LTD. (UNAUDITED) | |||||||||
Three months ended | Six months ended | ||||||||
2026 | 2025 | 2026 | 2025 | ||||||
Net income | |||||||||
Adjustments: | |||||||||
Gain on sale of equity investment | (4,324) | - | (4,324) | - | |||||
Income tax impact | 908 | - | 908 | - | |||||
Adjusted net income | |||||||||
Earnings per share | ||||||||
Basic | ||||||||
Diluted | ||||||||
Adjusted earnings per share | ||||||||
Basic | ||||||||
Diluted |
View original content:https://www.prnewswire.com/news-releases/tat-technologies-reports-record-second-quarter-2026-results-302843077.html
SOURCE